Abiopharma

🔍 Hedges Nancy L (Executive)

Company: ASTRONICS CORP (ATRO)

Report Date: 2026-06-15

Detailed Transactions and Holdings:

• Acquired 6,666 shares of $.01 PV CL B STK (Direct)
  Date: 2026-06-15 | Code: J | equity_swap_involved: 0 | shares_owned_after: 7,953.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of $.01 PV Com Stk (Direct)
  Date: 2026-06-15 | Code: H | shares_owned_after: 32,048.97
• Acquired 1,004 shares of Restricted Stock Unit (Derivative)
  Date: 2026-06-15 | Code: J | equity_swap_involved: 0 | shares_owned_after: 1,004.00 | transaction_form_type: 4 | Footnotes: F4, F1, F3, F3
• Acquired 3,540 shares of Restricted Stock Unit (Derivative)
  Date: 2026-06-15 | Code: J | equity_swap_involved: 0 | shares_owned_after: 3,540.00 | transaction_form_type: 4 | Footnotes: F4, F1, F5, F5
• Acquired 2,430 shares of Restricted Stock Unit (Derivative)
  Date: 2026-06-15 | Code: J | equity_swap_involved: 0 | shares_owned_after: 2,430.00 | transaction_form_type: 4 | Footnotes: F4, F1, F6, F6
• Holds 5,024 shares of Restricted Stock Unit (Derivative)
  Date: 2026-06-15 | Code: H | shares_owned_after: 5,024.00 | Footnotes: F2, F3, F3
• Holds 17,700 shares of Restricted Stock Unit (Derivative)
  Date: 2026-06-15 | Code: H | shares_owned_after: 17,700.00 | Footnotes: F2, F5, F5
• Holds 12,150 shares of Restricted Stock Unit (Derivative)
  Date: 2026-06-15 | Code: H | shares_owned_after: 12,150.00 | Footnotes: F2, F6, F6

Footnotes:

• F1: Shares issued pursuant to a one-for-five distribution of Class B stock to holders of both Common and Class B stock on the record date of June 15, 2026.
• F2: Each restricted stock unit represents the right to receive, at settlement, one share of common stock.
• F3: Vesting of these restricted stock units depends on Astronics Corp.'s average annual adjusted EBITDA for the period January 1, 2024- December 31, 2026. The "target" number of restricted stock units is reported. Between 50% and 150% of the target number of units may vest on February 22, 2027, with the vesting percentage determined based on actual performance.
• F4: Each restricted stock unit represents the right to receive, at settlement, one share of class B stock.
• F5: Vesting of these restricted stock units depends on Astronics Corp.'s average annual adjusted EBITDA for the period January 1, 2025- December 31, 2027. The "target" number of restricted stock units is reported. Between 50% and 150% of the target number of units may vest on February 27, 2028, with the vesting percentage determined based on actual performance.
• F6: Vesting of these restricted stock units depends on Astronics Corp.'s average annual adjusted EBITDA for the period January 1, 2026- December 31, 2028. The "target" number of restricted stock units is reported. Between 50% and 150% of the target number of units may vest on February 19, 2029, with the vesting percentage determined based on actual performance.